Prevalence of celiac disease in patients with hepatitis B and C virus related cirrhosis and cryptogenic liver cirrhosis.

被引:0
作者
Balkan, Ayhan [1 ]
Gulsen, Murat Taner [1 ]
Er, Ramazan Erdem [1 ]
Yildirim, Abdullah Emre [1 ]
Konduk, Bugra Tolga [1 ]
Barutcu, Sezgin [1 ]
机构
[1] Gaziantep Univ, Fac Med, Dept Gastroenterol, Univ Bulvari Sehitkamil, Gaziantep, Turkey
来源
BIOMEDICAL RESEARCH-INDIA | 2017年 / 28卷 / 08期
关键词
Celiac disease; Cryptogenic; Cirrhosis; Hepatitis b; Hepatitis c; TRANSGLUTAMINASE ANTIBODIES; HYPERTRANSAMINASAEMIA; DIAGNOSIS; GLUTEN;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Introduction: Celiac disease (CD) is a disease that involves many organs including the liver and is caused by autoimmune enteropathy. We aimed to compare the CD frequency between the cryptogenic cirrhosis and cirrhosis due to hepatitis B virus (HBV) and hepatitis C virus (HCV). Materials and methods: Patients with cryptogenic cirrhosis (n=83), HCV related cirrhosis (n=42) and HBV related cirrhosis patients (n=36) were enrolled to the study. Results: Abnormal celiac serology was present in 24 (14.9%) of 161 cirrhotic patients. In 6 of them (3.7%) CD was diagnosed. Remaining 18 patients had false positive celiac serology and biopsy results were not compatible with CD. The incidence of abnormal celiac serology in patients with cryptogenic cirrhosis was significantly higher than that of patients with HBV and HCV related cirrhosis (P<0.004). CD was not detected in patients with HBV related cirrhosis. Among HCV-related cirrhosis patients, 3 patients (7%) were diagnosed with CD. In cryptogenic cirrhosis patients, 3 patients (3.6%) were diagnosed with CD. Anti-tissue transglutaminase (anti-tTG) and anti-endomysium (EMA) IgA values were abnormal in all of the 6 CD patients diagnosed. Marsh type 3 changes were detected in duodenal biopsies of these patients Conclusions: The prevalence of CD in cirrhosis patients was 3 times higher than in the normal population. However, contrary to expectations, the prevalence of CD in HCV-associated cirrhotic patients was 2-fold higher than in patients with cryptogenic cirrhosis. These results show that in cryptogenic cirrhosis cases, there is no significancy of CD in etiology, but the ratio of abnormal celiac serology is increased.
引用
收藏
页码:3736 / 3741
页数:6
相关论文
共 28 条
[1]  
Adinolfi LE, 2001, AM J GASTROENTEROL, V96, P607, DOI 10.1111/j.1572-0241.2001.03574.x
[2]   Searching for coeliac disease in patients with non-alcoholic fatty liver disease [J].
Bardella, MT ;
Valenti, L ;
Pagliari, C ;
Peracchi, M ;
Farè, M ;
Fracanzani, AL ;
Fargion, S .
DIGESTIVE AND LIVER DISEASE, 2004, 36 (05) :333-336
[3]   Chronic unexplained hypertransaminasemia may be caused by occult celiac disease [J].
Bardella, MT ;
Vecchi, M ;
Conte, D ;
Del Ninno, E ;
Fraquelli, M ;
Pacchetti, S ;
Minola, E ;
Landoni, M ;
Cesana, BM ;
De Franchis, R .
HEPATOLOGY, 1999, 29 (03) :654-657
[4]   Fortnightly review - Coeliac disease [J].
Feighery, C .
BMJ-BRITISH MEDICAL JOURNAL, 1999, 319 (7204) :236-239
[5]  
Fine KD, 2001, AM J GASTROENTEROL, V96, P138, DOI 10.1111/j.1572-0241.2001.03464.x
[6]   Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: A general population-based study [J].
Fleming, Kate M. ;
Aithal, Guruprasad P. ;
Solaymani-Dodaran, Masoud ;
Card, Timothy R. ;
West, Joe .
JOURNAL OF HEPATOLOGY, 2008, 49 (05) :732-738
[7]   Coeliac disease and C virus-related chronic hepatitis: A non association [J].
Gravina A.G. ;
Federico A. ;
Masarone M. ;
Cuomo A. ;
Tuccillo C. ;
Loguercio C. ;
Persico M. ;
Romano M. .
BMC Research Notes, 5 (1)
[8]   PRIMARY SCLEROSING CHOLANGITIS AND CELIAC-DISEASE - A NOVEL ASSOCIATION [J].
HAY, JE ;
WIESNER, RH ;
SHORTER, RG ;
LARUSSO, NF ;
BALDUS, WP .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (09) :713-717
[9]   Chronic hepatitis C virus and celiac disease, is there an association? [J].
Hernandez, Lincoln ;
Johnson, Timothy C. ;
Naiyer, Afzal J. ;
Kryszak, Debby ;
Ciaccio, Edward J. ;
Min, Albert ;
Bodenheimer, Henry C., Jr. ;
Brown, Robert S., Jr. ;
Fasano, Allesio ;
Green, Peter H. .
DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (01) :256-261
[10]   Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study [J].
Kelly, C. P. ;
Green, P. H. R. ;
Murray, J. A. ;
DiMarino, A. ;
Colatrella, A. ;
Leffler, D. A. ;
Alexander, T. ;
Arsenescu, R. ;
Leon, F. ;
Jiang, J. G. ;
Arterburn, L. A. ;
Paterson, B. M. ;
Fedorak, R. N. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (02) :252-262